# Comparison of neurosurgical and medical management options of space-occupying cerebellar infarction

**Authors:** Cristian D. Mendieta-Barrera, Pavell Dhondt, Anuraag Punukollu, Fabricio Garcia-Torrico, Diana Laura Ochoa-Hernández, Rômulo da Silva Sanglard, Flor Belén Villalobos-Villalobos, Kevin Mamani-Julian, Luciana Rivera-Hurtado, Roel Meeus, Leonardo Rangel-Castilla, Arash Ghaffari-Rafi

PMC · DOI: 10.1007/s00701-026-06809-3 · Acta Neurochirurgica · 2026-03-06

## TL;DR

This study compares medical and surgical treatments for cerebellar infarctions, finding that surgery, especially a specific combined procedure, improves outcomes for patients with large infarcts or low consciousness.

## Contribution

The study identifies specific prognostic thresholds and surgical strategies that improve outcomes for space-occupying cerebellar infarctions.

## Key findings

- Surgical intervention improved outcomes for patients with infarct volumes >51 mL or GCS ≤13.
- SDC–N–EVD was the most effective surgical strategy, reducing mortality and hospital stay.
- Age and timing within 72 hours did not significantly affect outcomes.

## Abstract

Despite space-occupying cerebellar infarctions (SOCIs) carrying a high morbidity and mortality due to mass effect in the posterior fossa, optimal management remains uncertain: particularly regarding patient selection, timing, and surgical technique. We conducted a systematic review and network meta-analysis to compare outcomes between medical versus surgical management, and to identify prognostic thresholds that may guide treatment.

A search of PubMed, Embase, and CENTRAL was performed from database inception through October 30, 2024. Studies were included if they reported outcomes in ≥ 10 patients with SOCI treated with medical management and/or surgical interventions, including suboccipital decompressive craniectomy (SDC), external ventricular drainage (EVD), and necrosectomy. Data extraction and risk-of-bias assessment were performed independently by multiple reviewers. Random-effects meta-analyses and frequentist network meta-analyses were conducted. Primary outcomes were favorable functional status and mortality; secondary outcomes included length of hospital stay.

Eighteen studies comprising 754 patients met inclusion criteria. Surgical intervention was associated with superior outcomes in patients with infarct volumes > 51 mL (61.5% favorable outcome vs. 35.0% with medical therapy; p = 0.018) or GCS ≤ 13 (p < 0.05). Among surgical strategies, SDC combined with necrosectomy and an EVD (SDC–N–EVD) conferred the greatest probability of favorable outcome (OR 3.1, 95% CI: 1.18–8.14; p < 0.05), reduced mortality risk, and shortened length of hospitalization. Neither patient age nor surgical timing within 72 h significantly altered outcomes.

Surgical management, particularly SDC–N–EVD, was associated with improved outcomes compared to medical therapy alone for SOCI, especially in patients with large infarcts or impaired consciousness. Infarct volume and pre-interventional GCS can provide prognostic thresholds. While the inherent heterogeneity of the data indicates these results should be interpreted with caution, they provide impetus for conducting standardized multicenter prospective studies to validate these observations and establish evidence-based treatment algorithms.

The online version contains supplementary material available at 10.1007/s00701-026-06809-3.

## Full-text entities

- **Genes:** UBXN11 (UBX domain protein 11) [NCBI Gene 91544] {aka COA-1, PP2243, SOC, SOCI, UBXD5}
- **Diseases:** SCD (MESH:C536778), diabetes mellitus (MESH:D003920), DM (MESH:D009223), inflammatory (MESH:D007249), brainstem compression (MESH:D009408), neurological decline (MESH:D009461), cerebral edema (MESH:D001929), EVD (MESH:D065634), Stroke (MESH:D020521), atrial fibrillation (MESH:D001281), ischemic strokes (MESH:D002544), N (MESH:C536108), hypertension (MESH:D006973), impaired consciousness (MESH:D003244), death (MESH:D003643), herniation (MESH:D004677), hydrocephalus (MESH:D006849), Coma (MESH:D003128), neurologic deterioration (MESH:D009422), SDC (MESH:D003665), Cerebellar infarct (MESH:D007238)
- **Chemicals:** SDC (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967541/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12967541/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967541/full.md

---
Source: https://tomesphere.com/paper/PMC12967541